InvestorsHub Logo

loanranger

04/28/21 9:51 AM

#357255 RE: petemantx #357248

"If you have a pandemic, unheard of infections and deaths in India and Brazil and widespread cases worldwide, a drug that has been investigated for over a year at government RBLs, and yet you still can't fill a trial quickly one has to look at the process and see something is messed up (being politically correct) to a major degree."

So what's messed up exactly?

farrell90

04/28/21 1:26 PM

#357319 RE: petemantx #357248

I agree. I look for more help if the Phase2 trial produces positive results.

Grants, partnership offers, expedited trials, EUA or at least expanded compassionate use. I hope we can do something for India soon.

Just a few weeks away.

GLTA,Farrell

sox040713

04/28/21 3:35 PM

#357338 RE: petemantx #357248

Pete, looks like your estimate was off since you expected enrollment is near 100%. You really can't blame American politics since the majority of enrollment takes place in Russia. Try to look within the company if you can't find a blame outside.

If you have a pandemic, unheard of infections and deaths in India and Brazil and widespread cases worldwide, a drug that has been investigated for over a year at government RBLs with remarkably outstanding results, and yet you still can't fill a trial quickly one has to look at the process and see something is messed up (being politically correct) to a major degree.

Longpicker

04/29/21 12:40 PM

#357444 RE: petemantx #357248

I totally agree. In a Banana Republic the little guy gets squashed while the big guys skate right through, completely protected from any liability of course. Eventually facts will matter.

In response to:

“This trial progression says more about the state of medicine and the roadblocks put up for new drugs than it does regarding the worthiness of Brilacidin IMO. “